Tag:
eye treatments
Latest Headlines
Latest Headlines
Genentech pursues sustained-delivery version of blockbuster eye drug Lucentis
Ah, progress. Genentech has overcome an initial hurtle in its push to develop a sustained-delivery version of Lucentis , the company's blockbuster drug for age-related macular degeneration. The...
ISTA rebuffs Valeant bid
Well, that was quick. Executives at ISTA Pharmaceuticals ( $ISTA ) have mulled over Valeant Pharmaceutical's ( $VRX ) $327 million unsolicited initial bid for the company, and found it lacking. (Valeant
Hungry for ISTA, Valeant makes bid
Canada's Valeant Pharmaceuticals ( $VRX ) will push for at least one more acquisition before the holidays: U.S.-based rival ISTA Pharmaceuticals ($ISTA). The unsolicited bid for the California-based
